New Key Statistics Module, Z-Score and F-Score
NAS:KYMR Key Ratios
Market Cap $ M | 3,184.95 |
Enterprise Value $ M | 2,766.41 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.43 |
Price/Sales | 35.46 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 88.00 |
EPS (TTM) $ | -2.42 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -19.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -17.55 |
EV-to-EBITDA | -18.15 |
PEG | -- |
Shares Outstanding M | 64.58 |
Net Margin (%) | -178.27 |
Operating Margin % | -204.01 |
Pre-tax Margin (%) | -178.27 |
Quick Ratio | 8.45 |
Current Ratio | 8.45 |
ROA % (ttm) | -23.18 |
ROE % (ttm) | -30.10 |
ROIC % (ttm) | -67.14 |
Dividend Yield % | -- |
Altman Z-Score | 11.85 |
KYMR Number of Guru Trades
KYMR Volume of Guru Trades
Gurus Latest Trades with NAS:KYMR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KYMR is held by these investors
Total 2
Kymera Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KYMR
Total 0- 1